What is Wave Life Sciences's common stock?

Wave Life Sciences (WVE) reported common stock of $1.63B in Q1 2026.

How has Wave Life Sciences's common stock changed year-over-year?

Wave Life Sciences's common stock increased by 37.9% year-over-year, from $1.18B to $1.63B.

What is the long-term trend for Wave Life Sciences's common stock?

Over 5 years (2020 to 2025), Wave Life Sciences's common stock has grown at a 18.4% compound annual growth rate (CAGR), from $694.09M to $1.62B.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Wave Life Sciences WVE Common Stock

Common Stock at other companies

Eli LillyLLY

$590M-0.4%

Sarepta Therapeutics, Inc.SRPT

$11K+10.0%

Ionis PharmaceuticalsIONS

300M0.0%

Madrigal Pharmaceuticals, Inc.MDGL

200M0.0%

ALN

Alnylam PharmaceuticalsALNY

250M0.0%

Beam TherapeuticsBEAM

$1.03M+2.1%

Other financials

Income statement

See full

Revenue$38.2M+317%

Operating income-$31.3M+37.2%

Net income-$26.1M+44.4%

EPS (diluted)-$0.13+55.2%

Balance sheet

See full

Cash & equivalents$544.6M+124%

Total debt$15.7M-33.4%

Total equity$511.7M+198%

Total assets$583.5M+102%

Cash flow

See full

Operating cash flow-$59.6M+5.5%

CapEx$438.0K+165%

Free cash flow-$60.0M+5.1%

Valuation

See full

Market cap$1.14B+13.0%

Enterprise value$615.92M-22.3%

P/S15.1×-12.2×

Profitability

See full

Operating margin-75.7%-33.6pp

Net margin-66.5%-29.9pp

FCF margin-27.2%-12.6pp

Returns & leverage

See full

Return on equity-53.7%—

Debt / equity0×-0.1×

Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's common stock?: Wave Life Sciences (WVE) reported common stock of $1.63B in Q1 2026.
How has Wave Life Sciences's common stock changed year-over-year?: Wave Life Sciences's common stock increased by 37.9% year-over-year, from $1.18B to $1.63B.
What is the long-term trend for Wave Life Sciences's common stock?: Over 5 years (2020 to 2025), Wave Life Sciences's common stock has grown at a 18.4% compound annual growth rate (CAGR), from $694.09M to $1.62B.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).